130 related articles for article (PubMed ID: 9415596)
41. Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction.
Schönweiler R; Wohlfarth K; Dengler R; Ptok M
Laryngoscope; 1998 Jan; 108(1 Pt 1):55-63. PubMed ID: 9432068
[TBL] [Abstract][Full Text] [Related]
42. [Use of botulinum toxin type A in neuro-ORL].
Périé S; Lacau St Guily J
Ann Readapt Med Phys; 2003 Jul; 46(6):375-9. PubMed ID: 12928145
[TBL] [Abstract][Full Text] [Related]
43. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
[TBL] [Abstract][Full Text] [Related]
44. Botox for hyperadduction of the false vocal folds: a case report.
Rosen CA; Murry T
J Voice; 1999 Jun; 13(2):234-9. PubMed ID: 10442753
[TBL] [Abstract][Full Text] [Related]
45. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of laryngeal botulinum toxin injection: comparison of two techniques.
Fulmer SL; Merati AL; Blumin JH
Laryngoscope; 2011 Sep; 121(9):1924-8. PubMed ID: 22024846
[TBL] [Abstract][Full Text] [Related]
47. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
[TBL] [Abstract][Full Text] [Related]
48. Increased stability of airflow following botulinum toxin injection.
Finnegan EM; Luschei ES; Gordon JD; Barkmeier JM; Hoffman HT
Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837
[TBL] [Abstract][Full Text] [Related]
49. Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes.
Novakovic D; Waters HH; D'Elia JB; Blitzer A
Laryngoscope; 2011 Mar; 121(3):606-12. PubMed ID: 21298641
[TBL] [Abstract][Full Text] [Related]
50. [Indications for botulinum toxin in laryngectomy].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
[TBL] [Abstract][Full Text] [Related]
51. Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia.
Holden PK; Vokes DE; Taylor MB; Till JA; Crumley RL
Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):891-6. PubMed ID: 18217507
[TBL] [Abstract][Full Text] [Related]
52. The short-term impact of Botox injections on speech disability in adductor spasmodic dysphonia.
Epstein R; Stygall J; Newman S
Disabil Rehabil; 1997 Jan; 19(1):20-5. PubMed ID: 9021281
[TBL] [Abstract][Full Text] [Related]
53. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
[TBL] [Abstract][Full Text] [Related]
54. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia.
Bielamowicz S; Squire S; Bidus K; Ludlow CL
Ann Otol Rhinol Laryngol; 2001 May; 110(5 Pt 1):406-12. PubMed ID: 11372922
[TBL] [Abstract][Full Text] [Related]
55. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
Stong BC; DelGaudio JM; Hapner ER; Johns MM
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
[TBL] [Abstract][Full Text] [Related]
56. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of a portable, audible-only electromyography device in the treatment of spasmodic dysphonia.
Jeffcoat BT; Schweinfurth JM
Laryngoscope; 2008 May; 118(5):942-3. PubMed ID: 18197130
[No Abstract] [Full Text] [Related]
58. Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors.
Guglielmino G; Moraes BT; Villanova LC; Padovani M; Biase NG
Clinics (Sao Paulo); 2018 Jul; 73():e87. PubMed ID: 30020342
[TBL] [Abstract][Full Text] [Related]
59. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
Mendelsohn AH; Berke GS
Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
[TBL] [Abstract][Full Text] [Related]
60. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
